ArticleCancer medicine2019

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.

Nataliya Zhukova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.